Susquehanna International Group, LLP Yumanity Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.99 $87,516 - $170,742	-85,800 Reduced 85.2%	14,900 $27,000
Q1 2022 May 16, 2022	BUY	$0.97 - $3.27 $86,815 - $292,665	89,500 Added 799.11%	100,700 $151,000
Q4 2021 Feb 14, 2022	BUY	$2.81 - $10.48 $31,472 - $117,376	11,200 New	11,200 $33,000
Q2 2021 Aug 11, 2021	SELL	$11.27 - $19.64 $254,702 - $443,864	-22,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.69 - $22.52 $292,075 - $394,100	-17,500 Reduced 43.64%	22,600 $409,000
Q4 2020 Feb 16, 2021	BUY	$16.67 - $25.4 $668,467 - $1.02 Million	40,100 New	40,100 $682,000

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.